Technology Platform
Innovative technology platforms driving breakthroughs in universal cell therapy
Click the icon to learn more
Pipeline Layout
Neocytogen is focusing on universal cell and gene therapy, committed to developing innovative therapies for malignant tumors and chronic diseases.
| Product Code | Product Type | Indication | Product IND Target Timeline | |||
|---|---|---|---|---|---|---|
| 2025 | 2026 | 2027 | 2028 | |||
| NCG101 | Universal dual CAR-T | Lung cancer, breast cancer, ovarian cancer | ||||
| NCG201 | Universal TCR-NK | Renal cancer, liver cancer | ||||
| NCG301 | Universal CAR-M1 | Breast cancer, liver cancer, ovarian cancer | ||||
| NCG401 | RNA oncolytic virus | Lung cancer and other solid tumors | ||||
| NCG501 | iPSC exosome | Diabetic foot, dry eyes | ||||